We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Graft-versus-host disease/ Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.
- Authors
Massenkeil, G.; Rackwitz, S.; Genvresse, I.; Rosen, O.; Dorken, B.; Arnold, R.
- Abstract
Presents a study that evaluated the safety and efficacy of basiliximab in the therapy of steroid-refractory graft-versus-host disease after allogeneic stem cell transplantation. Methodology; Results; Discussion.
- Subjects
THERAPEUTICS; GRAFT versus host disease; STEM cell transplantation
- Publication
Bone Marrow Transplantation, 2002, Vol 30, Issue 12, p899
- ISSN
0268-3369
- Publication type
Article
- DOI
10.1038/sj.bmt.1703737